Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-01-25 @ 7:58 AM
Study NCT ID:
NCT00479167
Status:
TERMINATED
Last Update Posted:
2021-11-04
First Post:
2007-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Sponsor:
Rush University Medical Center
Organization: